Physician profile
Nathan Michael Ferda
NPI 1245625524
$963.28
in general payments reported to CMS, 2019-2025
21 companies · $36.05 in 2025
The $36.05 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $847 · 2022: $11.71 · 2023: $14.08 · 2024: $54.38 · 2025: $36.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $104.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $163.32 | 2019 | |
| Pfizer INC. | $101.73 | 2019 | |
| Lilly USA, LLC | $97.87 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $95.33 | 2019 | |
| Novo Nordisk INC | $74.13 | 2019 | |
| Exact Sciences Corporation | $44.70 | 2024-2025 | Cologuard Collection Kit |
| Amgen INC. | $43.95 | 2019-2025 | Repatha |
| Kowa Pharmaceuticals America, INC. | $41.67 | 2019 | |
| Glaxosmithkline, LLC. | $40.90 | 2019 | |
| Dynavax Technologies Corporation | $30.73 | 2024 | Heplisav-B |
| Ironshore Pharmaceuticals INC. | $28.67 | 2019 | |
| Astellas Pharma US INC | $28.61 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.38 | 2019 | |
| Janssen Pharmaceuticals, INC | $26.93 | 2019 | |
| Sanofi-Aventis U.S. LLC | $23.13 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $22.05 | 2019 | |
| Shionogi INC | $19.20 | 2019 | |
| Hologic Sales and Service, LLC | $14.08 | 2023 | Aptima |
| Allergan, INC. | $13.79 | 2019 | |
| Ironwood Pharmaceuticals, INC | $12.87 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $11.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Ferda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.